Yuan Fangfeng, Cui Junru, Wang Tianlei, Qin Jane, Jeon Ju Hyeong, Ding Huiming, Whittaker Charles A, Xu Renhuan, Cao Helen, Chen Jianzhu
Koch Institute for Integrative Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, MA, USA.
ARV Technologies, Inc., North Bethesda, MD, USA.
bioRxiv. 2024 Oct 12:2024.10.08.617156. doi: 10.1101/2024.10.08.617156.
Development of safe and effective subunit vaccines for controlling African Swine Fever Virus (ASFV) infection has been hampered by a lack of protective viral antigens, complex virion structures, and multiple mechanisms of infection. Here, we selected ASFV antigens based on their localization on the virion, known functions, and homologies to the subunits of the protective vaccinia virus vaccine. We also engineered viral capsid proteins for inducing optimal antibody responses and designed T cell-directed antigen for inducing broad and robust cellular immunity. The selected antigens in lipid nanoparticle-mRNA formulations were evaluated for immunogenicity in both mice and pigs with concordant results. Different antigens induced divergent immune response profiles, including the levels of IgG and T cell responses and effector functions of anti-sera. We further developed a computational approach to combine antigens into cocktails for inducing specific immune response profiles and validated candidate cocktail vaccines in mice. Our results provide a basis for further evaluating candidate subunit mRNA vaccines in challenge studies.
由于缺乏保护性病毒抗原、复杂的病毒粒子结构以及多种感染机制,用于控制非洲猪瘟病毒(ASFV)感染的安全有效亚单位疫苗的研发受到了阻碍。在此,我们根据病毒抗原在病毒粒子上的定位、已知功能以及与保护性痘苗病毒疫苗亚单位的同源性来选择ASFV抗原。我们还对病毒衣壳蛋白进行了改造,以诱导最佳抗体反应,并设计了针对T细胞的抗原,以诱导广泛而强大的细胞免疫。在脂质纳米颗粒-mRNA制剂中选择的抗原在小鼠和猪中均进行了免疫原性评估,结果一致。不同的抗原诱导出不同的免疫反应谱,包括IgG水平、T细胞反应以及抗血清的效应功能。我们进一步开发了一种计算方法,将抗原组合成鸡尾酒式疫苗以诱导特定的免疫反应谱,并在小鼠中验证了候选鸡尾酒疫苗。我们的结果为在攻毒研究中进一步评估候选亚单位mRNA疫苗提供了依据。